FRR Shares (Makes you Realise)

Equity

Home/ Are You A Trader/ Market Info/ Company Profile/ Smart Quotes

COMPANY PROFILE

ALKEM LABORATORIES LTD.

NSE : ALKEMBSE : 539523ISIN CODE : INE540L01014Industry : Pharmaceuticals & DrugsHouse : Private

BSE5018.4520.65 (+0.41 %)

PREV CLOSE (Rs.) 4997.80

OPEN PRICE (Rs.) 4993.45

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 1250

TODAY'S LOW / HIGH (Rs.)4992.55 5042.75

52 WK LOW / HIGH (Rs.)4498.9 6440

NSE5011.9013.3 (+0.27 %)

PREV CLOSE( Rs. ) 4998.60

OPEN PRICE (Rs.) 5025.00

BID PRICE (QTY) 5011.90 (1)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 78170

TODAY'S LOW / HIGH(Rs.) 4959.10 5040.00

52 WK LOW / HIGH (Rs.)4491.65 6439.9

More From Company Profile

Smart Quotes

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Trade Value (Rs. in Lacs)

62.74

Dividend Yield(%)

0.90

TTM EPS (Rs.)

174.78

P/E Ratio

28.71

Book Value (Rs.)

1030.56

Face Value (Rs.)

MCap (Rs. in Mn)

600030.97

Price/Earning (TTM)

25.28

Price/Sales (TTM)

6.81

Price/Book (MRQ)

4.87

PAT Margin (%)

23.22

ROCE (%)

19.66

Incorporation Year : 08-08 1973

Management Info :

Basudeo N Singh - Chairman Sandeep Singh - Managing Director

Registered Office :

Address : Alkem House,Senapati Bapat Marg,Lower Parel (West),
Mumbai,
Maharashtra-400013

Phone : 022 3982 9999

Email : investors@alkem.com / contact@alkem.com

Website : www.alkemlabs.com

Registrars Details :

MUFG Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE

NEWS

08Jul Alkem Laboratories informs about compl
Pursuant to Regulation 30 of the SEBI LODR Regulations, Alkem Laboratori..

18Jun Alkem Laboratories informs about chang
Alkem Laboratories has informed that Board of Directors at its meeting h..

11Jun Alkem Laboratories informs about analy
Provisions of the SEBI (Listing Obligations and Disclosure Requirements)..

Financials

	QTR Mar 25	ANNUAL 25
Net Profit	2769.4	22808.9
Gross Profit	2998.3	23035.4
Operating Profit	4083.8	26632.6
Net Sales	20449.4	88134.4

Rs. in Millions

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Torrent Pharma (BSE)

3602.50 (2.46%)

M.Cap (Rs. in Cr)121924.97

Pfizer (BSE)

5354.75 (1.23%)

M.Cap (Rs. in Cr)24496.77

Cipla (BSE)

1531.10 (2.95%)

M.Cap (Rs. in Cr)123674.79

Solara Active Pharma (BSE)

695.80 (5.85%)

M.Cap (Rs. in Cr)3350.49

Shareholding Pattern

	PROMOTERS	53.04%
	MUTUAL FUNDS/UTI	16.67%
	NON-INSTITUTION	16.05%
	FI/BANKS/INSURANCE	3.62%
	GOVERNMENT	0%
	FII	0%

Mf Holding

Scheme Name

Hold(%)

Tata Nifty MidSmall...

4.49

Motilal Oswal Nifty...

4.47

ICICI Pru Pharma He...

4.01

NJ ELSS Tax Saver S...

3.58

LIC MF Healthcare F...

3.50

ICICI Pru Nifty Pha...

3.36

Nippon India Nifty ...

3.36

Attention Investors

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month, Issued in the interest of Investors.

Risk Disclosure on Derivatives | Smart ODR | Mandatory Display | KYC Validation Links

BSE / NSE SEBI Registration No. INZ000279232, Depository Participant SEBI Registration No. – IN DP CDSL 132-2015

Mutual funds - ARN No. 81648 , Investment Adviser SEBI Registration No. : INA000008668.

close X

Download Client Registration Documents

Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do's & Don't's) in Vernacular Language :

Assamese Bengali Gujarati Hindi Kanada

Kashmiri Konkani Malyalam Marathi Oriya

Punjabi Sindhi Tamil Telegu Urdu

NOTE : " This document is a translated version of the client registration documents in English and is being provided in vernacular language to facilitate better understanding by the investors. In case of any ambiguity, the contents of the English version would prevail. "

CLOSE X

Risk Disclosures On Derivatives

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22